Targeting bone metastatic cancer: Role of the mTOR pathway.
about
Cell and Signal Components of the Microenvironment of Bone Metastasis Are Affected by HypoxiaCancer-targeted therapies and radiopharmaceuticalsEverolimus restrains the paracrine pro-osteoclast activity of breast cancer cells.The Effect of Everolimus in an In Vitro Model of Triple Negative Breast Cancer and Osteoclasts.Osteonecrosis of jaw beyond antiresorptive (bone-targeted) agents: new horizons in oncology.Pasteurella multocida toxin- induced osteoclastogenesis requires mTOR activation.The role of mTOR signaling pathway on cognitive functions in cerebral ischemia-reperfusion.Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines.
P2860
Q28072232-64936481-AD25-47B0-B7B4-D0D23E166E30Q35683440-037EE9A6-6B2C-459A-9711-C3918CF7E908Q35807838-AE604F2E-F070-48E7-B383-AC9325396E42Q38733725-0A08E4EF-C7BF-43AD-ABC0-EB3D13EDC9A3Q38807483-2D8E0CFD-2266-4A6A-9A34-EB584F3D4F65Q38835344-FF928BA8-7C5D-4365-8087-E02481572428Q41624588-AB983FEC-1C46-4E55-BCA5-5407C1A5E0EFQ49989200-9346578F-7A83-4C0E-9BB4-D7461A917698
P2860
Targeting bone metastatic cancer: Role of the mTOR pathway.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Targeting bone metastatic cancer: Role of the mTOR pathway.
@en
type
label
Targeting bone metastatic cancer: Role of the mTOR pathway.
@en
prefLabel
Targeting bone metastatic cancer: Role of the mTOR pathway.
@en
P2093
P50
P1476
Targeting bone metastatic cancer: Role of the mTOR pathway.
@en
P2093
Cinzia Ortega
Dino Amadori
Francesco Bertoldo
Francesco Cognetti
Franco Silvestris
Sabino De Placido
P304
P356
10.1016/J.BBCAN.2014.01.009
P407
P50
P577
2014-02-05T00:00:00Z